They are also generally in accord with the in vitro finding of others showing that prostate cancer cell proliferation can be altered by manipulating TTP levels [18], though our findings in PC-3 cells show that this does not occur through TTP targeting E2F1 expression (Supplementary Figure S7). The gene discussed is E2F1; the disease is prostate carcinoma.